Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Terminated 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 3Taxes 2Radiotherapy 2Radiosurgery 2Radiation 2Paclitaxel 2Nivolumab 2veliparib 1tislelizumab 1spartalizumab 1sotorasib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1enzalutamide 1apatinib 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Platinum 1Pemetrexed 1Morphine 1Midazolam 1Letrozole 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Fulvestrant 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma of Lung × Radiotherapy, Conformal × Clear all
NCT01386385 2026-05-26

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
53 enrolled 21 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡